FDA·Medicines·October 15, 2025

AvKARE recalls norgestimate and ethinyl estradiol tablets because they failed content uniformity specifications

The notice says these norgestimate and ethinyl estradiol tablets failed content uniformity specifications, and it covers 2192 cartons sold across the U.S.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
Company
AvKARE
Hazard
Failed Content Uniformity Specifications
Units
2192 cartons
Where sold
U.S. Nationwide
FDA classification
Class II · Ongoing
Classified by FDA
October 6, 2025
Recall started
September 2, 2025
FDA enforcement report
October 15, 2025
Identifiers
  • Codes: Lot # LF41138A; Exp 06/30/2027
  • FDA recall number: D-0007-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
Reason for recall
Failed Content Uniformity Specifications
Classification
Class II (Ongoing)
Distribution
U.S. Nationwide
Quantity
2192 cartons

Related recalls